{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:45:58Z","timestamp":1785743158957,"version":"3.56.0"},"reference-count":28,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatr. Rep.","Pediatric Reports"],"abstract":"<jats:p>Background\/Objective: In 2022, the American Academy of Pediatrics (AAP) revised the guidelines used to manage neonatal hyperbilirubinemia with a focus on reducing unnecessary testing and phototherapy. However, pediatricians\u2019 knowledge and compliance with the current guidelines have not been assessed. We conducted a survey to evaluate New Jersey pediatricians\u2019 current knowledge and practice patterns with the newly proposed guidelines. Patients and Methods: A questionnaire consisting of 28 closed-ended Likert-scale questions, along with demographic data, was distributed twice in 2024 to all members of the New Jersey AAP Chapter. Of 128 respondents, 120 who defined their involvement in the care of neonates with hyperbilirubinemia were analyzed. Results: The majority of survey respondents were general pediatricians (71.7%). Up to 70% recognized the risk factors for developing severe hyperbilirubinemia, except for Down Syndrome. Up to 60% of respondents utilized transcutaneous bilirubin in low-risk hyperbilirubinemia neonates and serum bilirubin after phototherapy initiation in high-risk neonates as recommended by the AAP. Almost all of the respondents followed the AAP recommended post-discharge follow-up and\/or bilirubin measurement. The majority reported phototherapy initiation at the recommended thresholds; however, only 12.5% of surveyed pediatricians followed the recommended threshold for phototherapy discontinuation. Conclusions: Surveyed pediatricians in our study were most likely to comply with the 2022 AAP guidelines; however, opportunities remain for improving pediatricians\u2019 awareness of specific risk factors, reducing unnecessary laboratory testing and discontinuation of phototherapy at the recommended level.<\/jats:p>","DOI":"10.3390\/pediatric18040101","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T06:17:40Z","timestamp":1785737860000},"page":"101","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Pediatricians\u2019 Practice Patterns on the Revised 2022 Neonatal Hyperbilirubinemia Guidelines"],"prefix":"10.3390","volume":"18","author":[{"given":"Estherline J.","family":"Thoby","sequence":"first","affiliation":[{"name":"Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimee","family":"Lariviere","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-9814-3867","authenticated-orcid":false,"given":"Katherine","family":"Briski","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Nemours Children\u2019s Health, Wilmington, DE 19803, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9358-656X","authenticated-orcid":false,"given":"Anna","family":"Petrova","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Rutgers Robert Wood Johnson Medical School, New Brunswick, NJ 08901, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"18","DOI":"10.21037\/pm-21-4","article-title":"Narrative review of the epidemiology of neonatal jaundice","volume":"4","author":"Hansen","year":"2021","journal-title":"Pediatr. Med."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Owerko, D., Ryan, K., Cabacungan, E., Yan, K., and Saudek, K. (2023). Neonatal hyperbilirubinemia: Assessing variation in knowledge and practice. PLoS ONE, 18.","DOI":"10.1371\/journal.pone.0282413"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1038\/s41390-021-01692-3","article-title":"Neonatal hyperbilirubinemia and bilirubin neurotoxicity in hospitalized neonates: Analysis of the US Database","volume":"91","author":"Qattea","year":"2022","journal-title":"Pediatr. Res."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Bi, B., Yang, Y., Su, J., and Deng, L. (2024). Analysis of pregnancy and neonatal outcomes in 100 pregnant women with Rh-negative blood type. BMC Pregnancy Childbirth, 24.","DOI":"10.1186\/s12884-024-06981-3"},{"key":"ref_5","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, Provisional Committee for Quality Improvement, and Subcommittee on Hyperbilirubinemia (1994). Practice parameter: Management of hyperbilirubinemia in the healthy term newborn. Pediatrics, 94, 558\u2013565.","DOI":"10.1542\/peds.94.4.558"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"American Academy of Pediatrics, and Subcommittee on Hyperbilirubinemia (2004). Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation. Pediatrics, 114, 297\u2013316.","DOI":"10.1542\/peds.114.1.297"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1542\/peds.2009-0329","article-title":"Hyperbilirubinemia in the newborn infant > or =35 weeks\u2019 gestation: An update with clarifications","volume":"124","author":"Maisels","year":"2009","journal-title":"Pediatrics"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e2022058859","DOI":"10.1542\/peds.2022-058859","article-title":"Clinical Practice Guideline Revision: Management of hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation","volume":"150","author":"Kemper","year":"2022","journal-title":"Pediatrics"},{"key":"ref_9","first-page":"95","article-title":"Implementation of the Revised American Academy of Pediatrics Clinical Practice Guidelines for hyperbilirubinemia Decreases Necessity for Serum Bilirubin and Phototherapy","volume":"51","author":"Michienzi","year":"2025","journal-title":"Jt. Comm. J. Qual. Patient Saf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e2023063323","DOI":"10.1542\/peds.2023-063323","article-title":"Bilirubin Measurement and Phototherapy Use After the AAP 2022 Newborn Hyperbilirubinemia Guideline","volume":"153","author":"Sarathy","year":"2024","journal-title":"Pediatrics"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1542\/hpeds.2022-007098","article-title":"Implementing Higher Phototherapy Thresholds for Jaundice in Healthy Infants 35 Plus Weeks","volume":"13","author":"Cahill","year":"2023","journal-title":"Hosp. Pediatr."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1542\/hpeds.2024-008205","article-title":"Impact of the 2022 AAP Guidelines on Neonatal Hyperbilirubinemia Admissions: A PHIS Study","volume":"15","author":"Jameel","year":"2025","journal-title":"Hosp. Pediatr."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1542\/hpeds.2025-008553","article-title":"Variability in Screening and Management of Hyperbilirubinemia Across US Hospitals: A BORN Study","volume":"16","author":"Leeds","year":"2026","journal-title":"Hosp. Pediatr."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jpeds.2019.12.039","article-title":"Early Hyperbilirubinemia in Neonates with Down Syndrome","volume":"219","author":"Bahr","year":"2020","journal-title":"J. Pediatr."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Huete-Garc\u00eda, A., and Otaola-Barranquero, M. (2021). Demographic Assessment of Down Syndrome: A Systematic Review. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph18010352"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e2024068026","DOI":"10.1542\/peds.2024-068026","article-title":"Phototherapy to Prevent Severe Neonatal Hyperbilirubinemia in the Newborn Infant 35 or More Weeks of Gestation: Technical Report","volume":"154","author":"Bhutani","year":"2024","journal-title":"Pediatrics"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2022059474","DOI":"10.1542\/peds.2022-059474","article-title":"Decreasing Bilirubin Serum Tests in Healthy Newborns During Birth Hospitalization","volume":"151","author":"Sukkar","year":"2023","journal-title":"Pediatrics"},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Petrova, A., Mehta, R., Birchwood, G., Ostfeld, B., and Hegyi, T. (2006). Management of neonatal hyperbilirubinemia: Pediatricians\u2019 practices and educational needs. BMC Pediatr., 6.","DOI":"10.1186\/1471-2431-6-6"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1542\/peds.101.1.25","article-title":"Practice patterns in neonatal hyperbilirubinemia","volume":"101","author":"Gartner","year":"1998","journal-title":"Pediatrics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1055\/s-0040-1718946","article-title":"Risk Factors and Predictors of Rebound Hyperbilirubinemia in a Term and Late-Preterm Infant with Hemolysis","volume":"39","author":"Almohammadi","year":"2022","journal-title":"Am. J. Perinatol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1542\/hpeds.2014-0074","article-title":"The utility of inpatient rebound bilirubin levels in infants readmitted after birth hospitalization for hyperbilirubinemia","volume":"5","author":"Berkwitt","year":"2015","journal-title":"Hosp. Pediatr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1111\/jpc.70124","article-title":"Real-World Outcomes of the 2022 American Academy of Pediatrics Hyperbilirubinemia Guideline","volume":"61","author":"Nissimov","year":"2025","journal-title":"J. Paediatr. Child Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"539","DOI":"10.3345\/cep.2024.01249","article-title":"Evaluation of total serum bilirubin thresholds for discontinuing phototherapy in jaundiced neonates: A randomized study","volume":"68","author":"Kumar","year":"2025","journal-title":"Clin. Exp. Pediatr."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Shoris, I., Gover, A., Toropine, A., Iofe, A., Zoabi-Safadi, R., Tsuprun, S., and Riskin, A. (2023). \u201cLight\u201d on Phototherapy-Complications and Strategies for Shortening Its Duration, A Review of the Literature. Children, 10.","DOI":"10.3390\/children10101699"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1197\/jamia.M2398","article-title":"Patient-care questions that physicians are unable to answer","volume":"14","author":"Ely","year":"2007","journal-title":"J. Am. Med. Inform. Assoc."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"e062158","DOI":"10.1136\/bmjopen-2022-062158","article-title":"Barriers and enablers to implementing clinical practice guidelines in primary care: An overview of systematic reviews","volume":"13","author":"Wang","year":"2023","journal-title":"BMJ Open"},{"key":"ref_27","doi-asserted-by":"crossref","unstructured":"Cunningham, C.T., Quan, H., Hemmelgarn, B., Noseworthy, T., Beck, C.A., Dixon, E., Samuel, S., Ghali, W.A., Sykes, L.L., and Jett\u00e9, N. (2015). Exploring physician specialist response rates to web-based surveys. BMC Med. Res. Methodol., 15.","DOI":"10.1186\/s12874-015-0016-z"},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0749-3797(00)00258-0","article-title":"Physician response to surveys. A review of the literature","volume":"20","author":"Kellerman","year":"2001","journal-title":"Am. J. Prev. Med."}],"container-title":["Pediatric Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2036-7503\/18\/4\/101\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:02:50Z","timestamp":1785740570000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2036-7503\/18\/4\/101"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":28,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["pediatric18040101"],"URL":"https:\/\/doi.org\/10.3390\/pediatric18040101","relation":{},"ISSN":["2036-7503"],"issn-type":[{"value":"2036-7503","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]}}}